<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
		>

<channel>
	<title>Ckalist | 2nd Phase | Activity</title>
	<link>https://ckalist.com/groups/2nd-phase/</link>
	<atom:link href="https://ckalist.com/groups/2nd-phase/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for the group, 2nd Phase.</description>
	<lastBuildDate>Mon, 30 Mar 2026 19:10:31 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=2.14.4</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
		
								<item>
				<guid isPermaLink="false">4b15d96fde94eca26aef9f1f7d157ad2</guid>
				<title>ctpintl joined the group 2nd Phase</title>
				<link>https://ckalist.com/activity/p/2043/</link>
				<pubDate>Sat, 10 Feb 2024 17:32:47 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">54cdfb013fde43f32eb5ca7b0901d08a</guid>
				<title>Ashley joined the group 2nd Phase</title>
				<link>https://ckalist.com/activity/p/1827/</link>
				<pubDate>Wed, 07 Feb 2024 20:08:43 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">527e9ebe8782cb85b981ed531c8d6c7e</guid>
				<title>Peter started the discussion 백내장 (Cataract)과 녹내장 (Glaucoma) in the forum 2nd Phase</title>
				<link>https://ckalist.com/groups/2nd-phase/forum/topic/%eb%b0%b1%eb%82%b4%ec%9e%a5-cataract%ea%b3%bc-%eb%85%b9%eb%82%b4%ec%9e%a5-glaucoma/</link>
				<pubDate>Tue, 02 Jan 2024 05:06:56 +0000</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://ckalist.com/groups/2nd-phase/forum/discussion/%eb%b0%b1%eb%82%b4%ec%9e%a5-cataract%ea%b3%bc-%eb%85%b9%eb%82%b4%ec%9e%a5-glaucoma/">백내장 (Cataract)과 녹내장 (Glaucoma)</a></p> <div class="bb-content-inr-wrap"><p>백내장(Cataract) 은 안구의 수정체가 혼탁해져서 시력장애를 일으키는 질병입니다. 수정체는 눈의 후방에 위치한 투명한 렌즈로, 빛을 모아 망막에 초점을 맞추는 역할을 합니다. 백내장이 발생하면 수정체가 혼탁해져서 빛이 제대로 통과하지 못하게 됩니다. 이로 인해 시야가 뿌옇게 보이고, 밝은 곳에서도 눈부심을 느끼게 됩니다.</p>
<p>녹내장 (Glaucoma) 은 시신경이 손상되는 질환입니다. 시신경은 망막에서 뇌로 시각 정보를 전달하는 역할을 합니다. 녹내장이 발생하면 시신경이 손상되어 시야가 좁아지고, 심한 경우 실명에 이를 수 있습니다.</p>
<p>백내장: 2020년 기준 전 세계적으로 약 2억 4,600만 명이&hellip;<span class="activity-read-more" id="activity-read-more-887"><a href="https://ckalist.com/groups/2nd-phase/forum/topic/%eb%b0%b1%eb%82%b4%ec%9e%a5-cataract%ea%b3%bc-%eb%85%b9%eb%82%b4%ec%9e%a5-glaucoma/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">ea192c206c5fc7110f0b84acdcff2988</guid>
				<title>Peter started the discussion 노안, 백내장 in the forum 2nd Phase</title>
				<link>https://ckalist.com/groups/2nd-phase/forum/topic/%eb%85%b8%ec%95%88-%eb%b0%b1%eb%82%b4%ec%9e%a5/</link>
				<pubDate>Tue, 02 Jan 2024 05:05:44 +0000</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://ckalist.com/groups/2nd-phase/forum/discussion/%eb%85%b8%ec%95%88-%eb%b0%b1%eb%82%b4%ec%9e%a5/">노안, 백내장</a></p> <div class="bb-content-inr-wrap"><p>최근 개발된 LAL은 다촛점렌즈의 문제점을 해결해줘서 백내장환자에게 좋은 결과를 보이고 있습니다. 아직까지는 전문의들이 많지않고 수술후 치료기간이 좀 길어서 전문의들이 썩 선호하지만 않는것 같은데, 환자들에게는 여러가지 장점을 제공해주고 있습니다.</p>
<p>실제 경험하신 분들이 참여해주면 좋겠습니다.</p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">428c44a667a58734546100d2a4c1296f</guid>
				<title>Desire joined the group 2nd Phase</title>
				<link>https://ckalist.com/activity/p/776/</link>
				<pubDate>Tue, 26 Dec 2023 00:41:18 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">3ffe0c574acb2ec453cb5b999a5d85ae</guid>
				<title>Peter created the group 2nd Phase</title>
				<link>https://ckalist.com/activity/p/745/</link>
				<pubDate>Sun, 24 Dec 2023 05:03:37 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>
		